Carolina Cancer Nanotechnology T32 Training Program
The Carolina Cancer Nanotechnology Training Program is a 24 to 36 month National Cancer Institute–sponsored T32 postdoctoral training program offered at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. The overarching goal of the CCNTP is to equip a cohort of outstanding young scientists with the multidisciplinary concepts and skills needed to improve cancer diagnosis and therapy based on concepts, tools and discoveries made in nanoscience and nanotechnology. These young scientists will successfully pursue careers in academia, industry, and government agencies, and they will become significant contributors to addressing emerging challenges in public health and medical research using nanotechnology to diagnose and treat cancer.
Each trainee’s research will be co-mentored by a physical scientist and a biomedical scientist, providing a unique multifaceted training experience leading to significant contributions to cancer nanotechnology. Additionally, trainees will participate in workshops and courses that will broaden their knowledge and conceptual understanding of all areas of cancer nanotechnology. The topics of these workshops will reflect many of the major themes of the Alliance for Nanotechnology in Cancer.
This Program is Currently Accepting Applications.
The Carolina Cancer Nanotechnology Training Program and the University of North Carolina at Chapel Hill are committed to the principles of diversity and equal opportunity and are particularly interested in receiving applications from a broad spectrum of people, including minorities, protected veterans, and individuals with disabilities.
The Carolina Cancer Nanotechnology Training Program is committed to providing reasonable accommodations. Individuals with disabilities seeking additional information about services available on the UNC campus may visit these sites: